Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study

AIDS Research and Therapy

Volumn 12, Issue 1, 2015, Pages

  Carballo, David ^a   Delhumeau, Cécile ^a   Carballo, Sebastian ^a   Bähler, Caroline ^b   Radovanovic, Dragona ^b   Hirschel, Bernard ^a   Clerc, Olivier ^c   Bernasconi, Enos ^d   Fasel, Dominique ^e   Schmid, Patrick ^f   Cusini, Alexia ^g   Fehr, Jan ^h   Erne, Paul ⁱ   Keller, Pierre Fréderic ^a,j   Ledergerber, Bruno ^h   Calmy, Alexandra ^a   Aubert, V ^j   Barth, J ^j   Battegay, M ^j   Bernasconi, E ^j   Boni J ^j   Bucher, H C ^j   Burton Jeangros, C ^j   Calmy, A ^j   Cavassini, M ^j   Egger, M ^j   Elzi, L ^j   Fehr, J ^j   Fellay, J ^j   Francioli, P ^j   Furrer, H ^j   Fux, C A ^j   Gorgievski, M ^j   Gunthard H ^j   Haerry, D ^j   Hasse, B ^j   Hirsch, H H ^j   Hirschel, B ^j   Hosli I ^j   Kahlert, C ^j   Kaiser, L K ^j   Keiser, O ^j   Kind, C ^j   Klimkait, T ^j   Kovari, H ^j   Ledergerber, B ^j   Martinetti, G ^j   Martinez de Tejada, B ^j   Metzner, K ^j   Muller N ^j   Nadal, D ^j   Pantaleo, G ^j   Rauch, A ^j   Regenass, S ^j   Rickenbach, M ^j   Rudin, C ^j   Schmid, P ^j   Schultze, D ^j   Schoni Affolter F ^j   Schupbach J ^j   Speck, R ^j   Taffe P ^j   Tarr, P ^j   Telenti, A ^j   Trkola, A ^j   Vernazza, P ^j   Weber, R ^j   Yerly, S ^j   more..

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f University Hospital   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ Peripherique Hospital Cardiology Department   (Switzerland)

^j Centre médical Ziggurat   (Switzerland)

more..

Author keywords

Coronary artery disease; Fatal outcome; HIV infection; Myocardial infarction

Indexed keywords

ANTIRETROVIRUS AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SMOKING; SURVIVAL RATE; SWITZERLAND;

EID: 84924126046     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/s12981-015-0045-z     Document Type: Article

References (36)

1. Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24(8):1228-30.
2. Berry SA, Fleishman JA, Moore RD, Gebo KA. Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. J Acquir Immune Defic Syndr. 2012;59(4):368-75.
3. Neuhaus J, Angus B, Kowalska JD, La Rosa A, Sampson J, Wentworth D, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5):697-706.
4. th Conference on Retroviruses and Opportunistic Infections 2013; Atlanta.
5. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013;14(4):195-207.
6. Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55(4):600-7.
7. Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, et al. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS. 2009;23(8):929-39.
8. Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS. 2008;22 Suppl 3:S19-26.
9. Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003;163(4):457-60.
10. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109(3):316-9.
11. Boccara F, Teiger E, Cohen A, Ederhy S, Janower S, Odi G, et al. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart. 2006;92(4):543-4.
12. Pearce D, Ani C, Espinosa-Silva Y, Clark R, Fatima K, Rahman M, et al. Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals. Am J Cardiol. 2012;110(8):1078-84.
13. Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, et al. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32(1):41-50.
14. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, Telenti A, et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol. 2010;39(5):1179-89.
15. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525-38.
16. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154-60.
17. Jialal I, Devaraj S. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342(25):1917-8.
18. Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart. 2010;96(12):917-21.
19. Radovanovic D, Urban P, Simon R, Schmidli M, Maggiorini M, Rickli H, et al. Outcome of patients with acute coronary syndrome in hospitals of different sizes. A report from the AMIS Plus Registry. Swiss Med Wkly. 2010;140(21-22):314-22.
20. Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149(9):618-26.
21. McNamara RL. Cardiovascular registry research comes of age. Heart. 2010;96(12):908-10.
22. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354(5):483-95.
23. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 2002;106(7):798-803.
24. Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother. 2011;66(9):2107-11.
25. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993-2003.
26. Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, et al. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation. 2013;127(17):1767-1774.
27. D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omede P, Sciuto F, et al. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33(7):875-80.
28. th Conference on Retroviruses and Opportunistic Infections 2013; Atlanta.
29. Radovanovic D, Nallamothu BK, Seifert B, Bertel O, Eberli F, Urban P, et al. Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011. Eur Heart J Acute Cardiovasc Care. 2013;1(3):183-91.
30. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614-22.
31. th Conference on Retroviruses and Opportunistic Infections 2013; Atlanta.
32. th Conference on Retroviruses and Opportunistic Infections. March 3-6, 2013. Atlanta. Abstract 62
33. Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379-86.
34. Arnold SV, Spertus JA, Masoudi FA, Daugherty SL, Maddox TM, Li Y, et al. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol. 2013;62(19):1791-801.
35. Daali Y, Ancrenaz V, Bosilkovska M, Dayer P, Desmeules J. Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients. Metabolism. 2011;60(11):1584-9.
36. Combescure C, Fontana P, Mallouk N, Berdague P, Labruyere C, Barazer I, et al. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(5):923-33.